Precision BioSciences DTIL 深 沪
等待开盘 04-02 09:30:00 美东时间
5.72
+0.220
+4.00%
华盛通- 最 高5.775
- 今 开5.45
- 成交量 6.18万股
- 最 低 5.45
- 昨 收 5.50
- 总市值 1.41亿
- 52周最高 8.82
- 市盈率 静 --
- 换手率 0.25%
- 52周最低 3.53
- 委 比 -79.10%
- 总股本 2472.67万
- 历史最高 710.10
- 量 比 0.40
- 振 幅 5.91%
- 历史最低 3.53
- 每 手 1
- 风险率 0.87%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BUZZ-Precision Bio rises after quarterly results beat estimates
BUZZ-Precision Bio rises after quarterly results beat estimates ** Shares of biotech firm Precision BioSciences DTIL.O rise 8.89% to $5.51 premarket ** Co posts Q4 profit of $1.05 per share, while analysts were expecting a loss of 54 cents per share, according to data compiled by LSEG ** Posts Q4 re
03-12 20:37
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
BRIEF-Precision BioSciences, Inc. Q4 Net Income USD 20.133 Million
BRIEF-Precision BioSciences, Inc. Q4 Net Income USD 20.133 Million Mar 12 (Reuters) - Precision BioSciences, Inc. Q4 revenue USD 34.204 million vs. IBES estimate USD 9.07 million. Q4 operating expenses USD 21.696 million Q4 income from operations USD 12.508 million
03-12 19:00
BUZZ-Precision Bio rises as U.S. patents bolster experimental hepatitis B therapy
BUZZ-Precision Bio rises as U.S. patents bolster experimental hepatitis B therapy ** Shares of biotech firm Precision BioSciences DTIL.O rise 1% to $5.32 premarket ** Co says the U.S. Patent and Trademark Office issued notices strengthening IP for PBGENE‑HBV, its experimental gene‑editing therapy f
03-11 19:14
Precision BioSciences shares are trading higher after the company announced presentation of new preclinical study data supporting the potential long-term efficacy of PBGENE-DMD.
Precision BioSciences shares are trading higher after the company announced pre...
03-11 01:23
BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers, Live Nation, NovaBridge
BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers, Live Nation, NovaBridge Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 20 (Reuters) - U.S. stock index futures tumbled more than
03-09 21:29
Precision BioSciences Lands $7.5M Milestone Payment From TG Therapeutics In MS Drug Trial
Precision BioSciences, Inc. (NASDAQ:DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today
03-02 20:12
Precision BioSciences Receives $7.5 Million Milestone Payment From TG Therapeutics for Azer-cel MS Trial Progress
Precision BioSciences Receives $7.5 Million Milestone Payment From TG Therapeutics for Azer-cel MS Trial Progress Precision BioSciences said it achieved a clinical milestone under its license agreement with TG Therapeutics tied to progress in a Phase 1 trial of azercabtagene zapreleucel (azer-cel) i
03-02 20:01
Precision BioSciences to Present PBGENE-DMD Preclinical Data at 2026 MDA Clinical & Scientific Conference
Precision BioSciences to Present PBGENE-DMD Preclinical Data at 2026 MDA Clinical & Scientific Conference Precision BioSciences Inc. (Nasdaq: DTIL) will present new preclinical data on its PBGENE-DMD in vivo gene editing program at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific
02-18 20:03
BUZZ-U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec
BUZZ-U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq rose to their highest in one week on Wednesday
02-11 23:44
